Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 12 of 25, showing 5 Applications out of 121 total, starting on record 56, ending on 60

# Protocol No Study Title Investigator(s) & Site(s)

56.

ECCT/15/02/05  
    An open-label clinical trial to assess the pharmacokinetics and safety of miltefosine allometric dose for the treatment of children with primary visceral leishmaniasis in Eastern Africa   
Principal Investigator(s)
1. Rashid Juma
Site(s) in Kenya
1. Kimalel Health Centre (Baringo county)
2. Kacheliba District Hospital (West Pokot county)
 
View

57.

ECCT/24/07/01   LCCC 2330
    Feasibility of intravaginal artesunate as adjuvant HPV & cervical precancer treatment among women living with HIV in Kenya: A Phase II trial   
Principal Investigator(s)
1. Chemtai Mungo
Site(s) in Kenya
Cervical Cancer Screening Program (CCSP) Lumumba Sub-County Hospital
 
View

58.

ECCT/20/11/01   GC vaccine study in kenya
    Protocol Title: USE OF BEXSERO IMMUNIZATION TO DETECT CROSS REACTIVE ANTIGENS AND ANTI-GONOCOCCAL ANTIBODIES IN KEY POPULATIONS IN KENYA.   
Principal Investigator(s)
1. Prof. Eduard Sanders
Site(s) in Kenya
The KEMRI-Wellcome Trust Research Programme (KWTRP) Kenya Medical Research Institute (KEMRI) / Wellcome Trust Centre for Geographic Medicine Research – Coast (CGMRC)
 
View

59.

ECCT/12/03/01  
    Role of Fish Oil Omega-3 Fatty Acids on Depression among HIV-Seropositive Pregnant Women in Nairobi: A Randomized Double-blind Controlled Trial   
Principal Investigator(s)
1. Rose Okoyo Opiyo
Site(s) in Kenya
1. Riruta Health Centre (Nairobi City county)
2. Kariobangi North Health Centre (Nairobi City county)
3. Mathare North Health Centre (Nairobi City county)
4. Kayole II Sub-district hospital (Nairobi City county)
 
View

60.

ECCT/23/07/01   POWWeR Health Study
    Single arm trial of menstrual cups among economically vulnerable women to reduce Bacterial vaginosis and STIs through reduced harmful sexual and menstrual practices (POWWeR Health Study): A Phase 2 Trial   
Principal Investigator(s)
1. Fredrick Otieno
2. Supriya Dinesh Mehta
Site(s) in Kenya
Nyanza Reproductive Health Society
 
View